Limbal Célula madre Deficiency

El estudio ” Autologous cultured corneal epithelium (CECA) for the treatment of corneal lesions associated with limbal stem cell deficiencyis the first clinical trial of this product manufactured at the LOEX laboratory. The culture of corneal epithelium strives to produce a reconstructed tissue with the therapeutical aim of treatment of limbal stem cell deficiency. The study is a phase I/phase II study with the goal to evaluate safety and efficacy of the CECA graft for the treatment of human patients suffering from limbal stem cell deficiency.

The trial is open to all genders. The inclusion of 5 minors is planned.


NBScience

organización de contratos de investigación

terapia con células madre